Serum antibodies to oxidised low-density lipoprotein. 1994

K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
March 1994, Lancet (London, England),
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
July 2017, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
August 1994, Lancet (London, England),
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
June 1994, Lancet (London, England),
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
January 1995, Scandinavian journal of rheumatology,
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
August 1996, Annals of the rheumatic diseases,
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
February 2016, Biochimica et biophysica acta,
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
April 1993, Lancet (London, England),
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
October 2001, Endocrine journal,
K Aho, and M Seuri, and J Leikola, and G Alfthan, and O Vaarala, and T Palosuo
January 1993, British heart journal,
Copied contents to your clipboard!